Taken together, our results demonstrate an unexpected involvement of DYRK1A in RAS/MEK/ERK signaling regulation in KMT2A-R ALL cells and illustrate that DYRK1A inhibitor-mediated cell cycle arrest is induced via ERK hyperphosphorylation. The gene discussed is MAP2K7; the disease is acute lymphoblastic leukemia.